Big Move For ARCA biopharma, Inc.
Tue, Sep 03, 2024 at 07:22 PM
ARCA biopharma, Inc. (ABIO:NASDAQ) soared at $28.8, representing a gain of 1052%. On Tue, Sep 03, 2024, ABIO:NASDAQ touched a New 2-Week High of $28.8. The stock appeared on our News Catalysts scanner on Tue, Sep 03, 2024 at 08:50 AM in the 'MERGER' category. From Tue, Aug 20, 2024, the stock recorded 55.56% Up Days and 60.00% Green Days
About ARCA biopharma, Inc. (ABIO:NASDAQ)
ARCA biopharma Inc is a biopharmaceutical company. The Company is engaged in developing genetically-targeted therapies for cardiovascular diseases. Its product candidate is Gencaro.
Top 10 Gainers:
- ARCA biopharma, Inc. (ABIO:NASDAQ), 1052%
- Unico American Corporation (UNAM:NASDAQ), 155.5%
- SRAX, Inc. (SRAX:NASDAQ), 133.33%
- Sify Technologies Limited (SIFY:NASDAQ), 99.61%
- Conifer Holdings, Inc. (CNFR:NASDAQ), 74.24%
- BranchOut Food Inc. (BOF:NASDAQ), 69%
- SPAR Group, Inc. (SGRP:NASDAQ), 65.52%
- Asset Entities Inc. (ASST:NASDAQ), 44.37%
- Sable Offshore Corp Com (SOC:NYSE), 39.13%
- Vaxcyte Inc. (PCVX:NASDAQ), 36.39%